Zusammenfassung
Die beiden Beschwerdekomplexe Mundtrockenheit und Mundschleimhautbrennen können durch verschiedenste Ursachen bedingt sein. So können für das "burning mouth syndrom" sowohl lokale oder regionale als auch systemische Ursachen verantwortlich sein. Erkrankungen der Mundschleimhaut können genetisch, entzündlich oder neoplastisch bedingt sein, auch Autoimmunerkrankungen und Allergien können ebenso wie verschiedene internistische Erkrankungen mit einem Brennen der Mundschleimhaut einhergehen. Ebenso müssen neurologische und psychiatrische Erkrankungen in der interdisziplinären Diagnostik abgeklärt werden, um idiopathische Formen zu erkennen. Ähnlich komplex sind die Ursachen der Mundtrockenheit. Neben einer mangelnden Flüssigkeitsaufnahme sind gerade bei älteren Patienten häufig auch Arzneimittelnebenwirkungen oder systemische Erkrankungen verantwortlich. Die Therapie richtet sich nach der zugrundeliegenden Erkrankung, bei unklaren Fällen kann eine symptomatische Therapie die Beschwerden lindern.
Abstract
Both sets of complaints, mouth dryness and a burning sensation of the oral mucosa, can have a variety of causes. Local and regional as well as systemic causes can be responsible for burning mouth syndrome. Diseases of the oral mucosa can have genetic, inflammatory, or neoplastic origins. Autoimmune diseases and allergies as well as different afflictions relating to internal medicine can be accompanied by a burning sensation in the oral mucosa. Neurological and psychiatric illnesses must be clarified during interdisciplinary diagnostics in order to identify idiopathic forms. The causes of mouth dryness are similarly complex. In addition to inadequate fluid intake, particularly in elderly patients, drug side effects or systemic diseases are frequently also responsible. Treatment is directed at the underlying disease; in ambiguous cases, symptomatic therapy can provide relief for medical complaints.
Literatur
Abdollahi M, Radfahr M (2003) A review of drug induced oral reactions. J Contemp Dent Pract 1: 10–31
Antico A (1996) Oral allergy syndrome induced by chestnut (Castanea sativa). Ann Allergy Asthma Immunol 77: 254
Bivona PL (1998) Xerostomia—A common problem among the elderly. N Y State Dent J 64: 46–52
Blom M, Dawidson I, Fernberg JO, Johnson G, Angmar-Mansson B (1996) Acupuncture treatment of patients with radiation-induced xerostomia. Oral Oncol, Eur J Cancer 32B: 182–190
Bogetto f, Maina G, Ferro G, Carbone M, Gandolfo S ( 1998) Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med 60: 378–385
Brunstrom JM (2002) Effects of mouth dryness on drinking behaviour and beverage acceptability. Physiol Behav 76: 423–429
Carrington J, Getter L, Brown RS (2001) Diabetic neuropathy masquerading as glossodynia. J Am Dent Assoc 132: 1549–1551
Certosimo AJ, O'Connor RP (1996) Oral electricity. Gen Dent 44: 324–326
Clifford TJ, Warsi MJ, Burnett CA, Lamey PJ (1998) Burning mouth in Parkinson's disease sufferers. Gerodontology 15: 73–78
Dayan D, Vered M, Paz T, Buchner A (2000) Aging of human palatal salivary glands: a histomorphometric study. Exp Gerontol 35: 85–93
Drage LA, Rogers RS (1999) Clinical assessment and outcome in 70 patients with complaints of burning or sore mouth symptoms. Mayo Clin Proc 74: 223–228
Duffey DC, Eversole LR, Abemayor E (1996) Oral lichen planus and ist association with squamous cell carcinoma: an update on pathogenesis and treatment implications. Laryngoscope 106: 357–362
Eguia-Del-Valle A, Aguirre-Urizar JM, Martinez-Conde R, Echebarria-Goikouria MA, Sagasta-Pujana O (2003) Burning mouth syndrome in the Basque country: a preliminary study of 30 cases. Med Oral 8: 84–90
Epstein JB, Marcoe JH (1994) Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 77: 135–140
Femiano F, Gombos F, Scully C, Busciolano M, Luca PD (2000) Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 6: 274–277
Ferraccioli GF, Salaffi F, De Vita S, Casatta L, Avellini C, Carotti M, Beltrami CA (1996) Interferon alpha-2 (IFNalpha2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. Clin Exp Rheumatol 14: 367–371
Field EA, Longman LP, Bucknall R, Kaye SB, Higham SM, Edgar WM (1997) The establishment of a xerostomia clinic: a prospective study. Br J Oral Maxillofac Surg 35: 96–103
Fox PC (1992) Salivary gland involvement in HIV-1 infection. Oral Surg Oral Med Oral Pathol 73: 168–170
Gallager FJ, Baxter DL, Denobile J, Taybos GM (1988) Glossodynia, iron deficiency anemia, and gastrointestinal malignancy. Report of a case. Oral Surg Oral Med Oral Pathol 65: 130–133
Gibson J, Lamey PJ, Lewis M, Frier B (1990) Oral manifestations of previously undiagnosed non-insulin dependent diabetes mellitus. J Oral Pathol Med 19: 284–287
Grötz KA, Henneicke von Zepelin HH, Kohnen R et al. (1999) Prospektive, doppelblinde Therapiestudie zur Prophylaxe der Radioxerostomie durch Cumarin/Troxerutin bei Patienten mit Kopf-Hals-Karzinomen. Strahlenther Onkol 175: 397–403
Harpenau LA, Plemons JM, Rees TD (1995) Effectiveness of low dose of cyclosporine in the management of patients with oral erosive lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endond 80: 161–162
Helfman RJ (1979) The treatment of geographic tongue with topical Retin-A-solution. Cutis 24: 179–180
Henderson L, Muir M, Mills PR, Spence E, Fox R, McCruden EA (2001) Oral health of patients with hepatitis C virus infection: a pilot study. Oral Dis 7: 271–275
Henricsson V, Axell T (1980) Palliative treatment of geographic tongue. Swed Dent J 4: 129–134
Hornstein OP (1998) Erkrankungen des Mundes. Kohlhammer, Stuttgart Berlin Köln
Izumi M, Eguchi K, Nakamura H, Takagi Y, Kawabe Y, Nakamura T (1998) Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome. Ann Rheum Dis 57: 464–469
Jaaskelainen SK, Forsell H, Tenovuo O (1997) Abnormalities of the blink reflex in burning mouth syndrome. Pain 73: 455–460
Jaaskelainen SK, Rinne JO, Forsell H, Tenovuo O, Kaasinen V, Sonninen P, Bergman J (2001) Role of the dopaminergic system in chronic pain—a fluorodopa-PET study. Pain 90: 257–260
Jha N, Seikaly H, McGaw T, Coulter L (2000) Submandibular salivary gland transfer prevents radiation-induced xerostomia. Int J Rad Oncol Biol Phys 46: 7–11
Kaaber S, Thulin H, Nielsen E (1979) Skin sensitivity to denture base materials in the burning mouth syndrome. Contact Dermatitis 5: 90–96
Katz J, Benoliel R, Leviner E (1986) Burning mouth sensation associated with fusospirochetal infection in edentulous patients. Oral Surg Oral Med Oral Pathol 62: 152–154
Kleinegger CL, Krolls SO (1996) Severe pernicious anemia presenting with burning mouth symptoms. Miss Dent Assoc J 52: 12–14
Kolb-Maurer A, Sitaru C, Rose C, Brocker EB, Goebeler M, Zillikens D (2003) Therapie des Lichen planus pemphigoides durch Acitretin und pulsweise verordnetes Kortikosteroid. Hautarzt 54: 268–273
Kopp S, Sebald WG, Plato G (2000) Kraniomandibuläre Dysfunktion—Eine Standortbestimmung. Man Med 38: 335–341
Lamey PJ, Hammond A, Allam BF, McIntosh WB (1986) Vitamine status of patients with burning mouth syndrome and the response to replacement therapy. Br Dent J 160: 81–84
List T, Lundeberg T, Lundström I, Lindström F, Ravald N (1998) The effect of acupuncture in the treatment of patients with primary Sjögren's syndrome—A controlled study. Acta Odontol Scand 56: 95–99
Loldrup D, Langemark M, Hansen HJ, Olesen J, Bech P (1989) Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology 99: 1–7
Maier H (2001) Therapie nichttumoröser Speicheldrüsenerkrankungen und postoperativer Komplikationen. Laryngorhinootologie 80 (Suppl): 89–114
Main DMG, Basker M (1983) Patients complaining of a burning mouth. Further experience in clinical assessment and management. Br Dent J 154: 206–211
Maina G, Vitalucci A, Gandolfo S, Bogetto F (2002) Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single blind study. J Clin Psychiatry 63: 38–43
Menard TW, Izutsu KT, Ensign WY, Keller PJ, Morton PH, Truelove EL (1984) Radioprotection by WR-2721 of gamma-irradiated rat parotid gland: effect of gland weight and secretion at 8–10 days post irradiation. Int J Radiat Oncol Biol Phys 10: 1555–1559
Miyamoto SA, Ziccardi VB (1998) Burning mouth syndrome Mt Sinai J Med 65: 343–347
Nähri TO, Meurman JH, Ainamo A (1999) Xerostomia and Hyposalivation—Causes, consequences and treatment in the elderly. Drugs Aging 15: 103–116
Nusair S, Rubinow A (1999) The use of pilocarpine in xerostomia and Sjögren's syndrome. Semin Arthritis Rheum 28: 360–367
Plato G (2001) Gesichtsschmerz aus manualmedizinischer Sicht. Man Med 39: 254–258
Pratt NE, Sodicoff M, Liss J, Davis M, Sinesi M (1980) Radioprotection of the rat parotid gland by WR-2721: morphology at 60 days post-irradiation. Int J Radiat Oncol Biol Phys 6: 431–435
Rhodus NL (1999) Sjögren's syndrome. Quintessence Int 30: 689–699
Rhodus NL, Bereuter J (2000) Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome. J Otolaryngol 29: 28–34
Riley JL, Gilbert GH, Heft MW (1998) Orofacial pain symptom prevalence: selective sex differences in the elderly? Pain 76: 97–104
Schell H, Hornstein OP, Deinlein E, Bauer G (1983) Epithelial cell proliferation of oral lichen planus in patients treated with an aromatic retinoid. Acta Derm Venerol (Stockh) 63: 66–68
Shiozawa S, Morimoto I, Tanaka Y, Shiozawa K (1993) A preliminary study on the interferon-alpha treatment for xerostomia of Sjögren's syndrome. Br J Rheumatol 32: 52–54
Trikkas G (1998) Further psychiatric considerations of glossodynia. Psychosomatics 39: 85–87
Ullmann W, Hoffmann M (1981) Glossitis rhombica mediana. Hautarzt 32: 571–574
van der Waal I (1992) Mundschleimhautbrennen. Dtsch Ärzteverlag, Köln
Vilaplana J, Romaguera C, Cornelana F (1994) Contact dermatitis and adverse oral mucous membrane reactions related to the use of dental prostheses. Contact Dermatitis 30: 80–84
Vivino FB, Al-Hashimi I, Khan Z et al. (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögrens syndrome. Arch Intern Med 159: 174–181
Woda A, Navez ML, Picard P, Gremeau C, Pichard-Leandri E (1998) A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain 12: 272–278
Yeh CK, Johnson DA, Dodds MW (1998) Impact of aging on human salivary gland function : a community-based study. Aging 10: 421–428
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maier, H., Tisch, M. Mundtrockenheit und Mundschleimhautbrennen. HNO 51, 739–747 (2003). https://doi.org/10.1007/s00106-003-0918-7
Issue Date:
DOI: https://doi.org/10.1007/s00106-003-0918-7